Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
EBIT Growth

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year EBIT Growth History

[Standalone]

Mar2023Mar2022Mar2021Mar2020Mar2019
   EBIT Growth(%) 176.19-129.3525.23319.20347.40

What is the latest EBIT Growth ratio of GENPHARMASEC ?

The latest EBIT Growth ratio of GENPHARMASEC is 176.19 based on Mar2023 Standalone results.
Year EBIT Growth
Mar2023176.19
Mar2022-129.35
Mar202125.23
Mar2020319.20
Mar2019347.40

How is EBIT Growth of GENPHARMASEC Trending?

Years EBIT Growth % Change
Mar2023 176.19
Positive
Mar2022 -129.35
Negative
Mar2021 25.23
-92.10
Mar2020 319.2
-8.12
Mar2019 347.4 -

Other Financial Ratios of GENPHARMASEC


Compare EBIT Growth ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹122.4 Cr -3.5% 4.3% 16.2% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹4,920.7 Cr -0.9% 16.7% 79.6% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹2,317.5 Cr -0.4% -0.7% 20% Stock Analytics
KIRI INDUSTRIES ₹1,912.4 Cr -2.4% 16.2% 26.8% Stock Analytics
BODAL CHEMICALS ₹993.1 Cr -1.3% 2.6% 16.9% Stock Analytics
BHAGERIA INDUSTRIES ₹779.5 Cr -1.8% 20.5% 36.6% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-3.5%

4.3%

16.2%

SENSEX

1.4%

2.5%

24.3%


You may also like the below Video Courses